Skip to main content
logo
Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.622
-0.078 (-4.59%)
At close: Mar 2, 2026

Oncopeptides AB Revenue

In the year 2025, Oncopeptides AB had annual revenue of 71.12M SEK with 124.72% growth. Oncopeptides AB had revenue of 18.57M in the quarter ending December 31, 2025, with 87.28% growth.

Revenue
71.12M
Revenue Growth
+124.72%
P/S Ratio
6.22
Revenue / Employee
948.24K
Employees
75
Market Cap
442.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202571.12M39.47M124.72%
Dec 31, 202431.65M-3.57M-10.14%
Dec 31, 202335.22M26.87M321.54%
Dec 31, 20228.36M-109.94M-92.94%
Dec 31, 2021118.30M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bio-Works Technologies AB63.11M
Elicera Therapeutics AB10.86M
Corline Biomedical AB8.59M
Medivir AB8.50M
Xintela AB2.96M
Lipum AB1.93M
FluoGuide318.79K
Infant Bacterial Therapeutics AB-1.00K
Revenue Rankings

Oncopeptides AB News

More News